Literature DB >> 31102712

Conditioning of myoblast secretome using mesenchymal stem/stromal cell spheroids improves bone repair.

Augustine M Saiz1, Marissa A Gionet-Gonzales2, Mark A Lee3, J Kent Leach4.   

Abstract

Local muscle loss associated with open fractures remains an obstacle to functional recovery and bone healing. Muscle cells secrete bioactive myokines that elicit autocrine and paracrine effects and initiate signaling pathways for regenerating damaged muscle and bone. Mesenchymal stem/stromal cells (MSCs) are under investigation for the regeneration of both muscle and bone through their potent secretome. Compared to monodisperse cells, MSC spheroids exhibit a more complex secretome with heightened therapeutic potential. We hypothesized that the osteogenic potential of myokines would be enhanced when myoblasts were exposed to the MSC spheroid secretome. Conditioned media from MSC spheroids increased osteogenic response of MC3T3 pre-osteoblasts compared to myokines from L6 myoblasts alone. This effect was synergistically enhanced when conditioned media of MSC spheroids was serially delivered to myoblasts and then osteoprogenitor cells in vitro. We then delivered myoblast-stimulated conditioned media in the presence or absence of syngeneic rat bone marrow stromal cells (rBMSCs) from alginate hydrogels to a rat critical-sized segmental defect. We observed increased bone formation in defects treated with conditioned media compared to rBMSCs alone, while bone formation was greatest in defects treated with both conditioned media and rBMSCs over 12 weeks. This foundational study demonstrates a novel approach for capitalizing on the paracrine signaling of muscle cells to promote bone repair and provides additional evidence of the synergistic interaction between muscle and bone.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; Mesenchymal stem/stromal cell; Muscle; Myokines; Secretome

Year:  2019        PMID: 31102712      PMCID: PMC6589400          DOI: 10.1016/j.bone.2019.05.018

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  34 in total

1.  Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma.

Authors:  Philipp Niemeyer; Katharina Fechner; Stefan Milz; Wiltrud Richter; Norbert P Suedkamp; Alexander T Mehlhorn; Simon Pearce; Philip Kasten
Journal:  Biomaterials       Date:  2010-02-11       Impact factor: 12.479

2.  Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects.

Authors:  Masashi Osugi; Wataru Katagiri; Ryoko Yoshimi; Takeharu Inukai; Hideharu Hibi; Minoru Ueda
Journal:  Tissue Eng Part A       Date:  2012-06-12       Impact factor: 3.845

Review 3.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

4.  An analysis of outcomes of reconstruction or amputation after leg-threatening injuries.

Authors:  Michael J Bosse; Ellen J MacKenzie; James F Kellam; Andrew R Burgess; Lawrence X Webb; Marc F Swiontkowski; Roy W Sanders; Alan L Jones; Mark P McAndrew; Brendan M Patterson; Melissa L McCarthy; Thomas G Travison; Renan C Castillo
Journal:  N Engl J Med       Date:  2002-12-12       Impact factor: 91.245

Review 5.  The epidemiology of open fractures in adults. A 15-year review.

Authors:  Charles M Court-Brown; Kate E Bugler; Nicholas D Clement; Andrew D Duckworth; Margaret M McQueen
Journal:  Injury       Date:  2011-12-27       Impact factor: 2.586

6.  Short-term muscle atrophy caused by botulinum toxin-A local injection impairs fracture healing in the rat femur.

Authors:  Yongqiang Hao; Yongcheng Ma; Xuepeng Wang; Fangchun Jin; Shengfang Ge
Journal:  J Orthop Res       Date:  2011-09-14       Impact factor: 3.494

7.  An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects.

Authors:  Yash M Kolambkar; Kenneth M Dupont; Joel D Boerckel; Nathaniel Huebsch; David J Mooney; Dietmar W Hutmacher; Robert E Guldberg
Journal:  Biomaterials       Date:  2010-09-22       Impact factor: 12.479

8.  Risk factors for and results of late or delayed amputation following combat-related extremity injuries.

Authors:  Melvin D Helgeson; Benjamin K Potter; Travis C Burns; Roman A Hayda; Donald A Gajewski
Journal:  Orthopedics       Date:  2010-09-07       Impact factor: 1.390

9.  Role of muscle-derived growth factors in bone formation.

Authors:  M W Hamrick; P L McNeil; S L Patterson
Journal:  J Musculoskelet Neuronal Interact       Date:  2010-03       Impact factor: 2.041

10.  Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model.

Authors:  Lorraine E Harry; Ann Sandison; Ewa M Paleolog; Ulrich Hansen; Michael F Pearse; Jagdeep Nanchahal
Journal:  J Orthop Res       Date:  2008-09       Impact factor: 3.494

View more
  3 in total

1.  Morphogen Delivery by Osteoconductive Nanoparticles Instructs Stromal Cell Spheroid Phenotype.

Authors:  Jacklyn Whitehead; Alefia Kothambawala; J Kent Leach
Journal:  Adv Biosyst       Date:  2019-10-01

2.  CORR Insights®: Do Patient-derived Spheroid Culture Models Have Relevance in Chondrosarcoma Research?

Authors:  Terri A Zachos
Journal:  Clin Orthop Relat Res       Date:  2021-03-01       Impact factor: 4.755

3.  Preclinical and Clinical Amelioration of Bone Fractures with Mesenchymal Stromal Cells: a Systematic Review and Meta-Analysis.

Authors:  Hanxiao Yi; Yang Wang; Qunying Liang; Xiaoqun Mao
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.